Lancer Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 4.00 Cr
- Company Age 19 Year, 4 Months
- Last Filing with ROC 31 Mar 2008
- Open Charges ₹ 5.45 Cr
About Lancer Life Sciences
Lancer Life Sciences Private Limited (LLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 September 2005 and has a history of 19 years and four months. Its registered office is in Hyderabad, Telangana.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2008. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹5.45 Cr.
Appi Tamma, Tamma Suneetha, Venkata Veera, and One other member serve as directors at the Company.
Company Details
-
LocationHyderabad, Telangana
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110TG2005PTC047502
-
Company No.
047502
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Sep 2005
-
Date of AGM
22 Aug 2008
-
Date of Balance Sheet
31 Mar 2008
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Lancer Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Appi Tamma
|
Managing Director | 16-Sep-2005 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Tamma Suneetha
|
Director | 31-Aug-2010 | Current |
|
Venkata Veera
|
Director | 31-Aug-2010 | Current |
|
Narasimha Gummadi
|
Director | 31-Aug-2010 | Current |
Financial Performance of Lancer Life Sciences.
Enhance accessibility to Lancer Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lancer Life Sciences?
Unlock access to Lancer Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Geneca Pharma Private LimitedAppi Tamma and Narasimha Gummadi are mutual person
Charges (Loans)
₹5.45 Cr
₹0
Charges Breakdown by Lending Institutions
- Syndicate Bank : 5.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Dec 2006 | Syndicate Bank | ₹5.45 Cr | Open |
How Many Employees Work at Lancer Life Sciences?
Unlock and access historical data on people associated with Lancer Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lancer Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lancer Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
